Skip to Content
  • Previous Rank132
  • Revenues ($M)$22,871.30
  • Revenue Percent Change7.8%
  • Profits ($M)$-204.1
  • Profits Percent Change-107.5%
  • Assets ($M)$44,981.00
  • Employees40,655
  • Market Value — as of March 29, 2018 ($M)$84,542.20

The pharmaceutical giant manufactures drugs for humans as well as for livestock and poultry.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

CEO
David A. Ricks
CEO Title
Chairman, President & Chief Executive Officer
Sector
Health Care
Industry
Pharmaceuticals
HQ Location
Indianapolis
Websitehttp://www.lilly.com
Years on Fortune 500 List24
Employees40,655

Eli Lilly Rank History

Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$22,871.307.8%
Profits ($M)$-204.1-107.5%
Assets ($M)$44,981.00-
Total Stockholder Equity ($M)$11,592.20-
Market Value — as of March 29, 2018 ($M)$84,542.20-

Profit Ratios

Profit as % of Revenues-0.9%
Profits as % of Assets-0.5%
Profits as % of Stockholder Equity-1.8%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)-0.19
EPS % Change (from 2016)-107.4%
EPS % Change (5 year annual rate)-
EPS % Change (10 year annual rate)-

Total Return

Total Return to Investors (2017)17.7%
Total Return to Investors (5 year, annualized)14.7%
Total Return to Investors (10 year, annualized)9%